Healthcare -
Biotechnology - NASDAQ - US
$ 4.41
-2.65 %
$ 204 M
Market Cap
-1.55
P/E
FDMT - CAPITAL EXPENDITURES
Capital Expenditures FDMT - 4D Molecular Therapeutics, Inc.
-2.77 M
LAST VALUE
44.85%
2 YEAR CAGR
-46.26%
5 YEAR CAGR
0.00%
10 YEAR CAGR